Sarcopenia represents an independent adverse event in metastatic castration-resistant prostate cancer (mCRPC) patients candidates to Radium-223 therapy

Abstract
Publication Date:
2021
Iris type:
01.05 Abstract in rivista
Keywords:
Sarcopenia; prostate cancer
List of contributors:
Authors of the University:
Handle:
https://iris.cnr.it/handle/20.500.14243/448329
Published in:
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (PRINT)
Journal